[Treatment of myasthenia with the aldosterone antagonist spironolactone].
D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006947:Hyperkalemia / Q000209:etiology; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists; D009157:Myasthenia Gravis / Q000150:complications / Q000188:drug therapy*; D013148:Spironolactone / Q000627:therapeutic use*
D002800:Cholinesterase Inhibitors; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone
Behandlung der Myasthenia mit dem Aldosteronantagonisten Spironolacton.